SCHEMBL5530765

SCHEMBL5530765

C#Cc1ccc(NC(=O)c2cc(OC)ccc2N(C=O)c2ccc(C=NN(C)C)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.40
F10 P00742 4/20 0.38
AURKA O14965 1/20 0.37
LMNA P02545 2/20 0.36
HPGD P15428 1/20 0.36
PLAU P00749 2/20 0.36
ALDH1A1 P00352 4/20 0.35
MAPT P10636 4/20 0.35
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35
F2 P00734 1/20 0.35
PLAT P00750 1/20 0.35
SIRT2 Q8IXJ6 1/20 0.35
TYK2 P29597 1/20 0.34
NPC1 O15118 3/20 0.34
GAA P10253 3/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5530351 0.91 F10 (0.36) POLBF10HPGDALDH1A1MAPT
SCHEMBL5532522 0.90 POLB (0.37) POLBF10AURKALMNAHPGD
SCHEMBL5528410 0.89 F10 (0.37) POLBF10LMNAHPGDPLAU
SCHEMBL5528201 0.88 F10 (0.46) POLBF10ALDH1A1MAPTSIRT2
SCHEMBL5531693 0.88 FGFR4 (0.38) POLBF10ALDH1A1MAPTHSD17B10
SCHEMBL5531583 0.81 F10 (0.34) POLBF10ALDH1A1MAPTF2
SCHEMBL5531871 0.81 MAPT (0.44) POLBLMNAHPGDALDH1A1MAPT
SCHEMBL5533584 0.81 NPC1 (0.44) POLBF10LMNAHPGDALDH1A1
SCHEMBL5533116 0.80 F10 (0.35) POLBF10LMNAALDH1A1MAPT
SCHEMBL5533680 0.80 F10 (0.33) F10MAPTF2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1373194-B1 BENZAMIDE INHIBITORS OF FACTOR Xa MILLENNIUM PHARM INC (US) 2007-08-01 EP claimed
EP-1373194-A1 BENZAMIDE INHIBITORS OF FACTOR Xa Millennium Pharmaceuticals, Inc. (US) 2004-01-02 EP claimed
WO-2002079145-A1 BENZAMIDE INHIBITORS OF FACTOR Xa MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-10-10 WO claimed
US-7312235-B2 Benzamide inhibitors of factor Xa MILLENNIUM PHARMACEUTICALS, INC. (US) 2007-12-25 US disclosed
US-20030069250-A1 Benzamide inhibitors of factor Xa MILLENNIUM PHARMACEUTICALS, INC. 2003-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069250-A1 Benzamide inhibitors of factor Xa SERPINC1, TFPI, F12 POLB 1818/4885F10 10/4885AURKA 3712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.